InsiderTrades

Form 4 for XENE Xenon Pharmaceuticals Inc.

Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001193125-26-102667 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-03-11 2026-03-09 XENE DiFabio Andrea CLO M - OptEx — +7,500 7,500 New —
DT 2026-03-11 2026-03-10 XENE DiFabio Andrea CLO S - Sale+OE $60.11 -2,607 4,893 -35% -$156.7K
DT 2026-03-11 2026-03-09 XENE DiFabio Andrea CLO M - OptEx $0.00 -7,500 0 -100% $0
DT 2026-03-11 2026-03-09 XENE DiFabio Andrea CLO A - Grant $0.00 +7,500 7,500 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2026-03-09 M A 7,500 — 7,500 D — — (F1) Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.
2 Common Common Shares 2026-03-10 S D 2,607 $60.11 4,893 D — —
3 Derivative Performance Share Units 2026-03-09 M D 7,500 $0.00 0 D — · — to — 7,500 Common Shares (F1) Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.
4 Derivative Performance Share Units 2026-03-09 A A 7,500 $0.00 7,500 D — · — to — 7,500 Common Shares (F1) Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.